Page 5 - ஜிங் லியூ News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஜிங் லியூ. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஜிங் லியூ Today - Breaking & Trending Today

AnHeart Announces Upcoming Presentation of Preliminary Results from Phase II Trial of Taletrectinib in ROS1+ NSCLC at the ASCO 2021 Virtual Meeting


Share:
HANGZHOU, China and NEW YORK, May 19, 2021 (GLOBE NEWSWIRE) AnHeart Therapeutics Co., Ltd. ( AnHeart ), a clinical stage oncology company focused on underserved patients in global markets, announces an upcoming presentation of an abstract selected for poster presentation from its ongoing Phase II trial of taletrectinib in ROS1 fusion positive Non-Small Cell Lung Cancer (NSCLC) (NCT04395677) at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting being held virtually on June 4-8, 2021. Details on the abstract and a corresponding poster presentation are shown below.
Abstract Number: 9066
Abstract Title:
Taletrectinib (AB-106; DS-6051b) in metastatic non-small cell lung cancer (NSCLC) patients with ROS1 fusion: Preliminary results of TRUST. ....

New York , United States , Irina Koffler , Akira Jing Liu , Anheart Therapeutics Co Ltd , Lifesci Advisors , American Society Of Clinical Oncology , Anheart Therapeutics Inc , Drug Administration , Tongji University , Business Development , Non Small Cell Lung Cancer , American Society , Clinical Oncology , Caicun Zhou , Shanghai Pulmonary Hospital , Lung Cancer , Non Small Cell , Anheart Therapeutics , Private Securities Litigation Reform Act , Heart Contact , Jing Liu , Relations Contact , Sci Advisors , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் ,